YEEDO News
-
New Achievement of Yeedozencom：Fluoxetine Hydrochloride Capsules of Qianyuan Pharmaceutical have Successfully Passed the Consistency Evaluation of Generic Drugs
Recently, Shanxi Qianyuan Pharmaceutical Group Co., Ltd. received "Drug Supplement Application Approval" of its Fluoxetine Hydrochloride Capsules, which was approved and issued by NMPA. The product has passed the “Consistency evaluation of generic drugs” .2020-03-17 -
Looking at Biomedical R&D trends from JPM Healthcare conference 2020
Innovative products / technologies will continue to be a key driver of focus in this area in 2020...2020-02-18 -
An Open Letter to Customers
We will maintain close communication with you, research institutions, suppliers by telephone, WeChat, email, and work together to mitigate the impact of the epidemic.2020-02-09 -
CDE Notice on Adjusting Drug Application Acceptance, Dossier Reception and Inquiry During Pneumonia Epidemic of Novel Coronavirus Infection
...2020-02-07 -
.png)
Gathering Strength for Win-Win in the Future
Proudly farewelling to the old year and happily starting the new year! On January 18, 2020, the YEEDOZENCOM 2019 annual party was held grandly at the Beijing Banquet restaurant. All the employees of YEEDOZENCOM gathered together for celebration.2020-01-21 -
YEEDOZENCOM Appears at China Focus @ San Francisco 2020
The China Focus @ San Francisco 2020 was solemnly held in San Francisco, the United States on January 12, local time. As the largest China theme docking event in the JP Morgan Conference Week, this conference attracted more than 50 senior executives from well-known Chinese and foreign pharmaceutical companies and investment institutions, roadshows of 40 innovative companies and nearly 700 participants from China, the United States, Europe, Canada, Japan, South Korea and other countries.2020-01-17
